Amgen Ventures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 2
Professionals
  • Investments
  • 82
  • Portfolio
  • 18
  • Exits
  • 41
Exits

Amgen Ventures General Information

Description

Founded in 2004, Amgen Ventures is the corporate venture arm of Amgen and is based in Thousand Oaks, California. The firm prefers to invest in early-stage biotechnology companies in oncology, immune-oncology, cardiovascular, inflammation, bone health, nephrology, metabolic disorders and neuroscience sectors.

Contact Information

Year Founded
2004
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Other Investor Types
Venture Capital
Primary Office
  • One Amgen Center Drive
  • Thousand Oaks, CA 91320
  • United States
+1 (805) 000-0000

Amgen Ventures Investments (82)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Imago BioSciences 19-Nov-2020 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 3
0000000 00 20-Aug-2020 00000 00000 0000 Other Healthcare Services Generating Revenue
000000 28-May-2020 00000 00000 0000 Other Healthcare Services Generating Revenue
0000000 13-May-2020 00000 00000 0000 Drug Discovery Generating Revenue
000 0000000000 02-Apr-2020 00000 00000 000.00 Biotechnology Generating Revenue
0000000 000000000 18-Feb-2020 00000 00000 0000 Therapeutic Devices Product Development 000000 00000
000 0000000000 07-Jan-2020 00000 00000 0000 Decision/Risk Analysis Generating Revenue
000000 00000000000 27-Aug-2019 00000 00000 00000 Biotechnology Generating Revenue/Not Profitable
Navan 25-Apr-2019 Seed Round 000 Biotechnology Generating Revenue 000000 00000
Imago BioSciences 15-Mar-2019 Later Stage VC 0000 Drug Discovery Clinical Trials - Phase 3
You’re viewing 10 of 82 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Amgen Ventures Exits (41)

Company Name Exit Date Exit Type Exit Size
Kymera Therapeutics 21-Aug-2020 IPO 00000
000000 00000000000 13-Jul-2020 000 00000
0000000 000 01-Jan-2020 0000000000: 000000
000000000 00000000 28-Mar-2019 000 00000
0000000 07-Feb-2019 000 00000
000000 00000000000 13-Jan-2019 0000000000: 000000
00000 000000000 27-Sep-2018 000 0000
0000000000 0000000 09-Jul-2018 000000000000000000
Surface Oncology 19-Apr-2018 IPO 00000
Flatiron 06-Apr-2018 Merger/Acquisition 00.00
You’re viewing 10 of 41 exits. Get the full list »

Amgen Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Amgen Ventures Team (8)

Name Title Deals Funds Boards Office
Janis Naeve Ph.D Managing Director 00 0 0 South San Francisco, CA
Gladys Nunez Principal 0 0 0 Cambridge, MA
Rachna Khosla Vice President, Business Development, Amgen Thousand Oaks, CA
You’re viewing 3 of 8 team members. Get the full list »